BioFocus: Driving innovation, inspiring collaboration
BioFocus by Bionow is a dynamic one-day conference uniting leaders from industry, academia, and the wider life sciences community.
Designed to spark collaboration and accelerate innovation, BioFocus offers a powerful platform to connect, engage, and create new opportunities for growth. The event features an inspiring programme of keynote talks, expert panels, exhibition and dedicated networking sessions.
Innovating Healthcare Through Personalisation
Discover how precision medicine is transforming the healthcare landscape at the 2026 Bionow Precision Medicine Conference. This event brings together thought leaders, innovators, and healthcare professionals to explore advancements in personalised treatment approaches and their impact on patients.
The conference will showcase keynote speeches, engaging panel discussions, interactive exhibitions, and exceptional networking opportunities.
Why Attend?
About Metrion
Metrion Biosciences (‘Metrion’) is a UK-based, ion channel focused Contract Research Organisation (CRO) providing high-quality in vitro preclinical drug discovery and safety profiling services. From our headquarters at Granta Park, Cambridge, we support a global customer base with cardiac safety profiling, ion channel drug discovery screening, medicinal chemistry screening support, and neuroscience assay services.
Role Summary
IRCA Group, a global leader in high-quality food ingredients, has signed a lease at Pioneer Group’s new food and beverage incubator, Gastronomica at Colworth Science Park in Bedfordshire.
IRCA has taken 405 sq ft of space in the facility, providing the company with a strong foothold in the UK market. A specialist in chocolate, creams, fillings, fruits, pistachios and decorations, IRCA currently operates 20 production facilities across Europe, the US, and Vietnam, serving customers in more than 100 countries.
Experienced biotech Chair and executive will guide corporate growth and development
Creative Biolabs introduces CAR-T therapy research solutions and webinars to help scientists drive innovation in CAR-T development.
Creative Biolabs, the world's leading biotechnological solutions provider, today announces its new comprehensive portfolio of solutions to accelerate chimeric antigen receptor T-cell (CAR-T) research. Through its industry-leading platforms, expert scientist guidance and educational webinars, Creative Biolabs is dedicated to helping scientists and research organizations solve technical challenges and drive innovation in CAR-T development.
At ImmuONE, our vision is to transform in vitro inhalation safety assessment by providing the best-in-class in vitro models and tailored in vitro services that most accurately predict in vivo outcomes. We have unique capabilities in the development and commercialisation of immunocompetent 2D and 3D in vitro models and assessments and work with the pharmaceutical, consumer product and chemical sectors globally to provide vital data on safety of new products and pharmacology and efficacy of new therapeutics.
Read Marks & Clerks AI Report 2025 here.
Stevenage, UK, 1 December 2025 - NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the appointment of Paul Thompson PhD as Chief Development Officer (CDO).